Concerns rise among smaller drugmakers

Published: 2009-07-17 06:59:00

Updated: 2009-07-17 06:59:00

The nation’s small- and medium–sized pharmaceutical companies are struggling to survive from leading pharmaceutical firms taking a stronger hold of the local market with a number of blockbuster generic drugs.

Market experts forecasted these companies will face more harsh condition in a couple ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK